controlled and uncontrolled hemodynamic and clinical studies have noted that the long-term treatment of patients with chronic heart failure with phosphodiesterase ( pde ) inhibitors , such as amrinone , milrinone , enoximone and imazodan , may accelerate progression of the underlying disease and provoke serious ventricular arrhythmias .
C0002697
amrinone
C0128513
milrinone